Anyagcsere betegségek újszülöttkori szűrése és klinikai jellemzőik [PDF]
Baráth Ákos +8 more
core
CRISPR/Cas9 gene therapy increases the risk of tumorigenesis in the mouse model of hereditary tyrosinemia type I. [PDF]
Chen T +13 more
europepmc +1 more source
Diagnosing alkaptonuria-related nephropathy with urine albumin analysis. [PDF]
Gülbahçe A, Muderrisoglu A.
europepmc +1 more source
Ochronotic Deposition in Alkaptonuria: Semiquinone-Mediated Oxidative Coupling and Metabolic Drivers of Homogentisic Acid Accumulation. [PDF]
Grasso D +5 more
europepmc +1 more source
Development of a radiographic vertebral severity score for evaluation of disease progression in alkaptonuria. [PDF]
Rossignol F +11 more
europepmc +1 more source
Inborn Errors of Amino Acid Metabolism Revisited: Clinical Implications and Insights into Current Therapies. [PDF]
Shakerdi AL +3 more
europepmc +1 more source
Integrating computational engines to identify <i>TSPAN6</i> as a migrasome-associated target for immunotherapy sensitization. [PDF]
Fang L, Pan H, Zhu Y.
europepmc +1 more source
Patient-reported outcomes and functional assessments of patients with Alkaptonuria in a 3-year Nitisinone treatment trial. [PDF]
Spears KR +10 more
europepmc +1 more source
Evaluation of Patients Diagnosed with Inherited Metabolic Diseases in Adulthood. [PDF]
Gulten ZA +3 more
europepmc +1 more source
Anthropometric, Body Composition, and Nutritional Indicators with and without Nutritional Intervention during Nitisinone Therapy in Alkaptonuria. [PDF]
Ranganath LR +11 more
europepmc +1 more source

